• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验中的重新随机化检验。

Re-randomization tests in clinical trials.

机构信息

Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Rockville, MD.

National Institutes of Health, National Institute of Allergy and Infectious Diseases, Rockville, MD.

出版信息

Stat Med. 2019 May 30;38(12):2292-2302. doi: 10.1002/sim.8093. Epub 2019 Jan 22.

DOI:10.1002/sim.8093
PMID:30672002
Abstract

As randomization methods use more information in more complex ways to assign patients to treatments, analysis of the resulting data becomes challenging. The treatment assignment vector and outcome vector become correlated whenever randomization probabilities depend on data correlated with outcomes. One straightforward analysis method is a re-randomization test that fixes outcome data and creates a reference distribution for the test statistic by repeatedly re-randomizing according to the same randomization method used in the trial. This article reviews re-randomization tests, especially in nonstandard settings like covariate-adaptive and response-adaptive randomization. We show that re-randomization tests provide valid inference in a wide range of settings. Nonetheless, there are simple examples demonstrating limitations.

摘要

由于随机化方法以更复杂的方式使用更多信息来分配患者接受治疗,因此分析由此产生的数据变得具有挑战性。只要随机化概率取决于与结果相关的数据,那么治疗分配向量和结果向量就会相关。一种简单的分析方法是重新随机化检验,该检验固定结果数据,并通过根据与试验中使用的相同随机化方法重复重新随机化,为检验统计量创建参考分布。本文回顾了重新随机化检验,特别是在协变量自适应和反应自适应随机化等非标准设置下。我们表明,重新随机化检验在广泛的设置中提供了有效的推断。尽管如此,仍有简单的示例表明了其局限性。

相似文献

1
Re-randomization tests in clinical trials.临床试验中的重新随机化检验。
Stat Med. 2019 May 30;38(12):2292-2302. doi: 10.1002/sim.8093. Epub 2019 Jan 22.
2
Weighted re-randomization tests for minimization with unbalanced allocation.用于不平衡分配最小化的加权重新随机化检验。
Pharm Stat. 2013 Jul-Aug;12(4):243-53. doi: 10.1002/pst.1577. Epub 2013 Jun 13.
3
A simulation study of outcome adaptive randomization in multi-arm clinical trials.多臂临床试验中结局自适应随机化的模拟研究。
Clin Trials. 2017 Oct;14(5):432-440. doi: 10.1177/1740774517692302. Epub 2017 Feb 1.
4
Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial.使用来自结果适应性随机试验的数据对生物标志物效应进行回顾性分析时的偏倚。
Clin Trials. 2019 Dec;16(6):599-609. doi: 10.1177/1740774519875969. Epub 2019 Oct 3.
5
Adaptive Randomization Method to Prevent Extreme Instances of Group Size and Covariate Imbalance in Stroke Trials.适应随机化方法预防卒中试验中极端的组间大小和协变量不均衡。
Stroke. 2024 Aug;55(8):1962-1972. doi: 10.1161/STROKEAHA.123.046269. Epub 2024 Jun 26.
6
A better alternative to stratified permuted block design for subject randomization in clinical trials.在临床试验中,用于受试者随机分组的分层随机区组设计的一种更好替代方法。
Stat Med. 2014 Dec 30;33(30):5239-48. doi: 10.1002/sim.6266. Epub 2014 Jul 14.
7
An evaluation of constrained randomization for the design and analysis of group-randomized trials with binary outcomes.对具有二元结局的群组随机试验的设计与分析中受限随机化的评估。
Stat Med. 2017 Oct 30;36(24):3791-3806. doi: 10.1002/sim.7410. Epub 2017 Aug 7.
8
Inference under covariate-adaptive randomization: A simulation study.协变量自适应随机化下的推断:一项模拟研究。
Stat Methods Med Res. 2021 Apr;30(4):1072-1080. doi: 10.1177/0962280220985564. Epub 2021 Jan 27.
9
Response-adaptive randomization for clinical trials with adjustment for covariate imbalance.用于临床试验的基于应答调整的自适应随机化方法:对协变量不均衡的调整
Stat Med. 2010 Jul 30;29(17):1761-8. doi: 10.1002/sim.3978.
10
Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.临床研究中的统计学争议:比较临床试验中适应性随机化的科学与伦理问题。
Ann Oncol. 2015 Aug;26(8):1621-8. doi: 10.1093/annonc/mdv238. Epub 2015 May 15.

引用本文的文献

1
A Two-Stage Covariate-Adjusted Response-Adaptive Enrichment Design.一种两阶段协变量调整的响应自适应富集设计。
Stat Biopharm Res. 2024;16(4):547-557. doi: 10.1080/19466315.2024.2308877. Epub 2024 Feb 26.
2
Response-adaptive randomization in clinical trials: from myths to practical considerations.临床试验中的响应自适应随机化:从误解到实际考量
Stat Sci. 2023 May;38(2):185-208. doi: 10.1214/22-STS865.
3
Novel clinical trial design and analytic methods to tackle challenges in therapeutic development in rare diseases.应对罕见病治疗研发挑战的新型临床试验设计与分析方法。
Ann Transl Med. 2022 Sep;10(18):1034. doi: 10.21037/atm-21-5496.
4
The Association of Lipids and Lipoproteins with Hip Fracture Risk: The Cardiovascular Health Study.血脂和脂蛋白与髋部骨折风险的关系:心血管健康研究。
Am J Med. 2022 Sep;135(9):1101-1108.e1. doi: 10.1016/j.amjmed.2022.05.024. Epub 2022 Jun 6.
5
A roadmap to using randomization in clinical trials.在临床试验中使用随机化的路线图。
BMC Med Res Methodol. 2021 Aug 16;21(1):168. doi: 10.1186/s12874-021-01303-z.
6
Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in the Netherlands (2014-17).产超广谱β-内酰胺酶大肠杆菌(ESBL-Ec)的比较基因组学研究揭示了 2014 年至 2017 年在荷兰,人类社区粪便和肠道外感染分离株中最常见的 10 种 ESBL-Ec 克隆和 ESBL 基因具有相似的分布。
J Antimicrob Chemother. 2021 Mar 12;76(4):901-908. doi: 10.1093/jac/dkaa534.
7
Prenatal and Infancy Nurse Home Visiting and 18-Year Outcomes of a Randomized Trial.产前和婴儿期护士家访与一项随机试验的 18 年结果。
Pediatrics. 2019 Dec;144(6). doi: 10.1542/peds.2018-3876. Epub 2019 Nov 20.
8
Impact of Multidomain Lifestyle Intervention on Frailty Through the Lens of Deficit Accumulation in Adults with Type 2 Diabetes Mellitus.多领域生活方式干预对 2 型糖尿病成人衰弱影响的研究——基于缺陷积累视角。
J Gerontol A Biol Sci Med Sci. 2020 Sep 25;75(10):1921-1927. doi: 10.1093/gerona/glz197.